Jefferies Initiates Ultragenyx Pharmaceutical At Buy

Analysts at Jefferies initiated coverage on shares of Ultragenyx RARE with a Buy rating. The target price for Ultragenyx is set to $74. Ultragenyx's shares dropped 0.97% to close at $54.19 yesterday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: InitiationAnalyst RatingsJefferies
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!